We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6066:HKEXCSC Financial Co., Ltd. Class H Analysis

Data as of 2026-06-11 - not real-time

HK$11.52

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading just above its short‑term moving average, with the 20‑day SMA providing a modest floor and the 50‑day SMA also supporting the price. Momentum indicators have turned bullish, as the MACD line sits above its signal, while the RSI hovers around the midpoint, suggesting no immediate overbought pressure. Volume has been on the rise, reinforcing the upward bias, and price is holding above a clear support zone but still below the next resistance level.
Fundamental strengths: Valuation metrics are notably attractive, with the price‑to‑earnings multiple well below the sector average and a price‑to‑book ratio under one, indicating a discount to book value. Revenue is expanding rapidly, operating margins are exceptionally high for a financial services firm, and cash flow generation comfortably covers dividend payments, which are supported by a modest payout ratio and a yield that ranks among the higher‑yielding peers. Despite a high debt‑to‑equity ratio, the company holds a substantial cash surplus, mitigating balance‑sheet concerns in the near term.
Valuation perspective: Discounted cash flow analysis points to a meaningful upside potential, and analyst price targets cluster well above the current level, reinforcing the view that the market is undervaluing the business. The combination of low valuation multiples, strong earnings growth, and a solid dividend makes the stock an appealing entry point for value‑oriented investors.
Risk considerations: The stock exhibits elevated short‑term volatility and carries a degree of leverage risk, while operating within a sector that is sensitive to regulatory changes in China. Nonetheless, its beta is low, liquidity is healthy, and the dividend appears sustainable, which together temper the overall risk profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover supporting near‑term upside
  • Price holding above short‑term support with increasing volume
  • Attractive valuation relative to peers

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high operating margins
  • Sustainable dividend yield with low payout ratio
  • DCF‑derived upside and analyst price targets above current levels

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Robust cash surplus offsetting high leverage
  • Strategic position in China’s capital‑markets ecosystem
  • Potential regulatory headwinds balanced by low market beta

Key Metrics & Analysis

Financial Health

Revenue Growth61.40%
Profit Margin43.50%
P/E Ratio9.1
ROE9.71%
ROA1.63%
Debt/Equity290.77
P/B Ratio0.9
Op. Cash FlowHK$93.1B
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI50.4
SupportHK$10.91
ResistanceHK$12.00
MA 20HK$11.49
MA 50HK$11.28
MA 200HK$12.49
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Fair ValueHK$309.77
Target PriceHK$16.09
Upside/Downside39.65%
GradeUndervalued
TypeBlend
Dividend Yield3.33%

Risk Assessment

Beta0.81
Volatility34.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.